04:36 PM EDT, 09/12/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Thursday it closed an offering of 12.33-million shares, raising approximately $8.5 million.

Each common share was sold at an offering price of $0.69 per share.

The biotech company intends to use the net proceeds from the offering for working capital requirements, general corporate purposes, and the advancement of business objectives.

BriaCell shares closed down $0.03 to $0.84 on the Toronto Stock Exchange.